As the U.S. pharmaceutical industry breathes a collective sigh of relief, Adents is urging pharma manufacturers to take full advantage of the Drug Supply Chain Security Act’s one-year enforcement postponement.
And get access to unlimited world-class packaging reporting and commentary.